Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.7513
+0.0013 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7400
-0.0113 (-1.50%)
After-hours: Sep 18, 2026, 7:05 PM EDT

Akso Health Group Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Cash & Equivalents
0.1711.13176.2391.3785.179.217.929.9918.4315.46
Short-Term Investments
-----0.05----
Cash & Short-Term Investments
0.1711.13176.2391.3785.179.267.929.9918.4315.46
Cash Growth (YoY)
-99.90%-87.82%106.91%886.32%974.82%-7.28%-57.00%-35.37%21.82%-29.43%
Accounts Receivable
1.283.170.950.41-5.837.77.93-0.02
Other Receivables
---------6.05
Receivables
1.285.8712.90.41-5.839.237.93206.56
Inventory
0.20.190.190.20.191.231.690.97.8-
Prepaid Expenses
-----0.56----
Other Current Assets
187.891.26.818.2456.65-1.622.0516.580.29
Total Current Assets
189.5518.39196.12100.21142.0216.8820.4620.8762.8122.31
Property, Plant & Equipment
0.030.090.110.24---0.04-0.07
Goodwill
-11.0410.83112.5------
Other Intangible Assets
0.066.857.88-------
Other Long-Term Assets
-175.66-------10.15
Total Assets
189.63212.04214.95212.95142.0216.8820.4620.9162.8132.52

Liabilities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Accounts Payable
---0.26------
Accrued Expenses
1.841.741.461.291.0910.941.20.230.94
Short-Term Debt
2.35226.65210.049.699.6937.212
Current Portion of Leases
0.020.040.040.04------
Current Income Taxes Payable
0.090.240.090.130.090.090.10.090.090.03
Other Current Liabilities
4.417.9910.223.860.420.420.9-13-
Total Current Liabilities
8.7112.0213.8112.233.5911.5511.6210.9850.5212.97
Long-Term Leases
00.020.040.06------
Long-Term Deferred Tax Liabilities
-1.691.95-------
Total Liabilities
8.7113.7315.812.33.5911.5511.6210.9850.5212.97

Shareholders' Equity

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Common Stock
0.260.260.170.070.040.010.010.010.010.01
Additional Paid-In Capital
405.53405.53405.62273.05210.3271.0271.0271.0271.0271.02
Retained Earnings
-217.58-200.18-198.9-64.51-63.93-57.93-54.47-52.3-53.11-45.17
Treasury Stock
-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99-3.99
Comprehensive Income & Other
-3.28-3.31-3.77-4.06-4.09-3.89-3.85-4.83-1.65-2.32
Total Common Equity
180.93198.3199.12200.56138.375.228.739.9112.2819.55
Minority Interest
-0.010.010.030.090.060.110.110.020-
Shareholders' Equity
180.92198.31199.15200.65138.425.338.849.9312.2919.55
Total Liabilities & Equity
189.63212.04214.95212.95142.0216.8820.4620.9162.8132.52

Additional Metrics

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Total Debt
2.382.062.086.75210.049.699.6937.212
Net Cash (Debt)
-2.219.07174.1584.6283.17-0.77-1.760.3-18.773.46
Net Cash Growth (YoY)
--89.29%109.38%-----91.19%-81.81%
Net Cash Per Share
-0.000.020.520.361.16-0.03-0.080.01-0.20
Filing Date Shares Outstanding
856.7856.7551.86239.9145.7222.8722.8722.8722.8722.87
Total Common Shares Outstanding
856.7856.7551.86239.9145.7222.8722.8722.8722.8722.87
Working Capital
180.846.37182.3187.98138.425.338.849.8912.299.34
Book Value Per Share
0.210.230.360.840.950.230.380.430.540.86
Tangible Book Value
180.88180.41180.4188.06138.375.228.739.9112.2819.55
Tangible Book Value Per Share
0.210.210.330.370.950.230.380.430.540.86
Machinery
0.020.020.02----0.13--
SEC Filings: 10-K · 10-Q